Aia America, Inc. v. Eli Lilly & Company

NOTE: This disposition is nonprecedential. United States Court of Appeals for the Federal Circuit ______________________ AIA AMERICA, INC., FKA ALZHEIMER'S INSTITUTE OF AMERICA, INC., Plaintiff-Appellant MICHAEL J. MULLAN, RONALD E. SEXTON, Counterclaim Defendants v. ELI LILLY & COMPANY, ELAN PHARMACEUTICALS, INC., Defendants-Appellees ______________________ 2016-2094 ______________________ Appeal from the United States District Court for the Northern District of California in No. 3:10-cv-00482-EDL, Magistrate Judge Elizabeth D. Laporte. ______________________ JUDGMENT ______________________ PETER BUCKLEY, Fox Rothschild, LLP, Philadelphia, PA, argued for plaintiff-appellant. DEBORAH E. FISHMAN, Arnold & Porter Kaye Scholer LLP, Palo Alto, CA, argued for all defendants-appellees. Defendant-appellee Elan Pharmaceuticals, Inc. also represented by KATIE JEANNINE LEWIS SCOTT. LAWRENCE SCOTT BURWELL, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Reston, VA, for de- fendant-appellee Eli Lilly & Company. Also represented by CHARLES E. LIPSEY; LAURA POLLARD MASUROVSKY, Washington, DC; MANISHA A. DESAI, Eli Lilly and Com- pany, Indianapolis, IN. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (NEWMAN, LOURIE, and HUGHES, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36. ENTERED BY ORDER OF THE COURT August 10, 2017 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court